ArticleBMC infectious diseases2019

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.

Lefteris Floros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.